Cipla Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:	500087	NSE Symbol:	CIPLA	P/E :	28.97
ISIN Demat:	INE059A01026	Div & Yield %:	0.98	EPS :	45.81
Book Value:	423.39	Market Cap (Rs. Cr.):	107,204.87	Face Value :	2

Date	Headline
13-May-26	Cipla appoints President & Global Chief – Integrated Product Development
17-Apr-26	Cipla's Goa unit completes USFDA inspection with two observations
01-Apr-26	Cipla to conduct board meeting
30-Mar-26	Cipla announces resignation of Umang Vohra as MD and Global CEO
24-Dec-25	Cipla declare Quarterly Result
10-Dec-25	Cipla receives ESG rating of 66
25-Sep-25	Cipla to announce Quarterly Result
11-Aug-25	Cipla sees marginal decline in ESG rating
05-Aug-25	Cipla updates on USFDA cGMP inspection of its Bommasandra unit
02-Jul-25	Cipla to conduct board meeting

Company Snapshot